Who provides lyophilization services for injectable drug products?

Several contract development and manufacturing organizations (CDMOs) provide lyophilization (freeze-drying) services for sterile injectable drug products, spanning clinical trial supply to commercial manufacturing.

Top Providers of Pharmaceutical Lyophilization Services

What to Expect from Lyophilization CDMOs

• Cycle Optimization: Developing customized temperature and pressure parameters for heat-sensitive biologics or small molecules.
• Aseptic Processing: Maintaining strict sterility controls via isolator technology and automated loading systems.
• Regulatory Compliance: Operating under current Good Manufacturing Practices (cGMP ) to support clinical trials and commercial release.

If you'd like, let me know:

• Are you looking for clinical scale or commercial scale production?
• Do you need assistance with formulation development or tech transfer of an existing cycle?

I can help narrow down the most suitable partner for your project.

Yes. A number of CDMOs (contract development and manufacturing organizations) provide lyophilization/freeze-drying for sterile injectable drug products, typically bundled with aseptic fill-finish, formulation, analytical testing, and packaging.

Notable providers

If you're selecting a provider

The most important distinction is whether you need development-scale lyophilization or commercial GMP manufacturing. I'd evaluate:

• Vial/batch capacity and maximum fill volume
• Whether they do lyo cycle development and optimization in-house
• Aseptic filling immediately before lyophilization
• Biologic vs. small-molecule experience
• Containment capabilities for potent/cytotoxic compounds
• Clinical vs. commercial GMP capacity
• Freeze-dryer configuration, shelf area, condenser capacity, and loading/unloading
• Ability to perform residual moisture, reconstitution, CCI, potency and stability testing
• Regulatory track record and experience with FDA/EMA submissions
• Tech-transfer and scale-up capabilities

For example, Thermo Fisher, Pfizer CentreOne, Recipharm, and Samsung Biologics are particularly relevant if you're looking for substantial clinical-to-commercial infrastructure, while Sharp Sterile and Pyramid may be attractive for smaller clinical programs.

If you tell me (1) biologic or small molecule, (2) clinical or commercial stage, (3) approximate batch size/vials, and (4) preferred geography, I can narrow this to 5–10 CDMOs that are genuinely suitable, including their lyophilizer capacities and locations.

Yes. A number of CDMOs/CMOs provide lyophilization (freeze-drying) for sterile injectable drug products, typically as part of an integrated formulation → sterile filling → lyophilization → inspection/packaging service.

Some prominent providers include:

For example, Thermo Fisher reports production of 130+ million sterile liquid and lyophilized vials annually, with lyophilized vial formats from 2–100 mL. www.patheon.com Recipharm specifically offers development and optimization of lyophilization cycles followed by scale-up to commercial production.

PCI is another particularly relevant option if you need cycle development + sterile fill-finish + lyophilization, including for complex formulations such as mAbs, proteins, nanoparticles and oligonucleotides.

If you're looking for a vendor for a specific injectable

The best provider depends heavily on the product. I can narrow this to 5–10 qualified CDMOs if you tell me:

• Molecule: small molecule, peptide, protein/mAb, vaccine, etc.
• Stage: preclinical, Phase I/II/III, or commercial
• Batch size / vial count
• Vial size and fill volume
• Whether you need lyophilization cycle development or just GMP manufacturing
• U.S.-only vs. worldwide
• Any high-potency/cytotoxic or containment requirements

I can also put together a CDMO comparison with lyophilizer capacity, vial formats, development vs. commercial capability, geographic location, and estimated fit for your program.

Lyophilization (freeze-drying) services for sterile injectable drug products are provided by specialized Contract Development and Manufacturing Organizations (CDMOs) with cGMP-compliant aseptic fill-finish capabilities.

Prominent global and regional providers equipped with sterile vial filling and lyophilization facilities include:

• Catalent – Provides integrated development, analytical, and commercial-scale sterile lyophilization and fill-finish services across an extensive global network.
• Simtra BioPharma Solutions (formerly part of Baxter) – Specializes in sterile contract manufacturing, complex injectable formulations, and high-capacity freeze-drying.
• Thermo Fisher Scientific (Patheon) – Offers comprehensive sterile liquid and lyophilized drug product manufacturing via isolator and RABS-equipped facilities.
• Lonza – Delivers large- and small-molecule aseptic fill-finish services, including specialized lyophilization for vials, ampoules, and complex injectables.
• Piramal Pharma Solutions – Operates dedicated sterile manufacturing and lyophilization facilities (such as its site in Lexington, Kentucky) tailored for injectables.
• Vetter Pharma – Focuses heavily on aseptic filling and lifecycle support for complex injectables, including freeze-dried formats.
• Lifecore Injectables – Offers specialized clinical and commercial cGMP manufacturing for sterile injectable and lyophilized products.
• Lyophilization Technology, Inc. (LTI) – A boutique CDMO entirely dedicated to the science, formulation development, cycle optimization, and clinical manufacturing of freeze-dried healthcare items.
• PCI Pharma Services – Expands into sterile fill-finish and clinical-to-commercial packaging capabilities suited for sensitive biologic injectables.

If you would like to narrow down these options, please share:

• Whether you need clinical trial batches (Phase I/II/III) or commercial-scale manufacturing
• The specific drug modality (e.g., small molecule, monoclonal antibody, peptide, or vaccine)
• Preferred geographic region (North America, Europe, or Asia)

I can help you pinpoint the most suitable CDMO partner for your project.

Yes. A number of CDMOs/CMOs provide lyophilization (freeze-drying) for injectable drug products, typically as part of an integrated sterile fill-finish offering. Some of the more established providers include:

These capabilities are documented by the providers themselves. PCI, for example, specifically describes lyophilization cycle development, sterile manufacturing, and fill-finish for complex sterile injectables. pci.com Recipharm similarly offers development and optimization of lyophilization cycles followed by scale-up to commercial production. www.recipharm.com Pfizer CentreOne describes both liquid and lyophilized sterile injectable manufacturing across its U.S. and European network.

If you're looking for a U.S. provider

I'd put PCI, Pfizer CentreOne, Thermo Fisher/Patheon, AbbVie CMO, and Pyramid near the top of the initial RFQ list. There are also more specialized providers such as Sharp/Berkshire Sterile Manufacturing, which specifically offers sterile injectable development/manufacturing and lyophilization.

If you tell me (1) drug type—small molecule, peptide, mAb/biologic, vaccine, etc., (2) vial/syringe format, (3) clinical vs. commercial stage, and (4) approximate batch size, I can narrow this to 5–10 CDMOs that are the best fit, including facility location, lyophilizer capacity, vial sizes, development capabilities, and whether they handle potent/cytotoxic products.

Lyophilization (freeze-drying) services for injectable and parenteral drug products are primarily provided by specialized Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) . These entities manage everything from formulation development and cycle optimization to aseptic fill-finish and commercial manufacturing.

Key providers of lyophilization services for injectables include:

• Specialized Lyophilization CDMOs
  • Lyophilization Technology, Inc. (LTI) : Dedicated specifically to freeze-drying and aseptic processing of healthcare products, serving pre-clinical through clinical and commercial requirements.
  • Biopharma Group / Biopharma Technology : Offers specialized R&D, consultancy, and small-batch/clinical freeze-drying in dedicated cleanrooms.
• Global and Full-Service CDMOs
  • Patheon (Thermo Fisher Scientific) : Provides extensive global network capabilities for sterile liquid and lyophilized injectables, highly potent compounds, and complex biologics.
  • Curia (formerly AMRI) : Offers comprehensive drug substance and drug product manufacturing, including sterile fill-finish and freeze-drying across various international sites.
  • AbbVie Contract Manufacturing : Delivers robust technical transfer, process optimization, and lyophilized vial/syringe fill-finish operations.
• Regional and Aseptic Specialists
  • Symbiosis Pharmaceutical Services : Specializes in sterile GMP manufacturing and bulk/vial lyophilization for biologics and clinical/commercial supply.
  • Famar S.A. : Features wide experience in sterile dosage forms, glass vial aseptic filling, and freeze-drying processing.
  • Coriolis Pharma : Focuses heavily on formulation development, particle analysis, and lyophilization specifically tailored for biologics and advanced injectables.

If you have a specific project in mind, let me know:

• Is your injectable a small molecule or a biologic/monoclonal antibody?
• Are you looking for clinical trial quantities or commercial scale manufacturing?
• Do you have a preferred geographic region (North America, Europe, etc.)?

I can help narrow down the ideal CDMO partner for your specifications.

Yes. There are quite a few CDMOs (contract development and manufacturing organizations) that provide lyophilization/freeze-drying for sterile injectable drug products, usually as part of an integrated formulation → sterile fill → lyophilization → stoppering/inspection → packaging service.

Major providers

Thermo Fisher specifically reports production of 130+ million sterile liquid and lyophilized vials annually, with lyophilized-vial formats from 2–100 mL. www.patheon.com PCI explicitly offers both lyophilization cycle development and sterile fill-finish & lyophilization for biologics and sterile injectables. pci.com Samsung likewise describes scalable freeze-drying capacity integrated into its cGMP drug-product suites.

urlThermo Fisher / Patheon sterile fill-finishturn0search3
urlPCI Pharma Services sterile manufacturingturn0search2
urlCatalent drug-product CDMO servicesturn0search1
urlSamsung Biologics drug-product servicesturn0search9
urlUI Pharmaceuticals sterile manufacturingturn0search0

If you're looking for a vendor for a specific injectable

The best provider depends heavily on batch size, molecule type, development stage, and whether you need only lyophilization or complete aseptic fill-finish.

For example, I can narrow this to 10–15 CDMOs that will actually take smaller batches and compare:

• minimum batch/vial quantities
• development vs. commercial capability
• lyophilizer shelf area/capacity
• vial sizes
• biologic vs. small-molecule experience
• U.S. locations
• FDA/cGMP status
• formulation & cycle-development capability
• sterile filling + lyo vs. lyophilization-only
• likely fit for Phase I/II vs. commercial

If you tell me roughly product type (e.g., peptide, small molecule, monoclonal antibody), vial size, and batch size, I can make a much more targeted shortlist.

A wide range of specialized Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) provide lyophilization (freeze-drying) and sterile fill-finish services for injectable drug products.

Leading global providers and specialized firms handling lyophilized injectables include:

• Simtra BioPharma Solutions (formerly Baxter BioPharma Solutions)—Specializes in aseptic fill-finish and complex lyophilization for sterile injectables.
• Catalent —Offers extensive global clinical and commercial scale sterile vial filling and freeze-drying capabilities.
• Thermo Fisher Scientific (Patheon) —Provides integrated sterile drug product development, manufacturing, and lyophilization services.
• Lonza —A major global CDMO with broad sterile manufacturing and biopharmaceutical stabilization expertise.
• Vetter Pharma —Specializes in aseptic fill and finish, including complex injectables, clinical, and commercial manufacturing.
• Curia (formerly AMRI)—Provides end-to-end discovery, development, and sterile drug product manufacturing, including lyophilization.
• Lifecore Injectables —Focuses heavily on difficult-to-handle and sterile injectable formulations, spanning clinical to commercial scales.
• Lyophilization Technology, Inc. (LTI) —A niche CDMO focused exclusively on freeze-drying cycle design, formulation, and clinical manufacturing.

If you are looking for a partner, could you share more details about your project:

• Is your injectable a small molecule or biologic (protein, peptide, vaccine)?
• What development phase are you in (preclinical, Phase I/II clinical trials, or commercial)?
• Do you need assistance with formulation development/cycle design or just fill-finish manufacturing?

Lyophilization (freeze-drying) services for sterile, injectable, and parenteral drug products are provided by specialized Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) . These organizations handle everything from early-stage formulation development and cycle optimization to aseptic vial filling and commercial manufacturing.

Prominent providers in this space include:

• Lyophilization Technology, Inc. (LTI) – A dedicated CDMO specializing exclusively in all aspects of pharmaceutical lyophilization, product/cycle design, and clinical trial material manufacturing for therapeutic/prophylactic injections.
• Curia (formerly AMRI) – A global contract research and manufacturing organization providing comprehensive discovery, development, and drug product manufacturing, including sterile injectables and biologics.
• Biopharma Group – Offers comprehensive R&D, pre- and post-lyophilization analytical services, formulation development, and clinical fill-finish manufacturing.
• Liof Pharma – Specializes in aseptic manufacturing, cold chain solutions, and lyophilization of biologicals and complex injectable drugs.
• AbbVie Contract Manufacturing – Provides trusted sterile manufacturing capabilities, encompassing specialized fill-finish and freeze-drying services.
• Pfizer CentreOne (PC1) – The contract manufacturing arm of Pfizer, offering global sterile injectables and active pharmaceutical ingredient expertise.

Are you looking for services at the clinical trial scale or commercial scale , and does your injectable formulation require high-potency/cytotoxic containment?

Many contract development and manufacturing organizations (CDMOs) provide lyophilization (freeze-drying) services for sterile injectable drug products, ranging from formulation development through commercial aseptic fill-finish. The best choice depends on your development stage, batch size, product type (small molecule, biologic, peptide, vaccine, etc.), and geographic preferences.

Some well-known providers include:

Other major CDMOs with established sterile injectable and lyophilization capabilities include:

• Catalent
• Curia
• Vetter
• Sharp
• Argonaut Manufacturing Services
• AbbVie Contract Manufacturing

When evaluating a lyophilization partner, it's useful to assess:

• Experience with your dosage form (vials, dual-chamber syringes, cartridges)
• Ability to develop and validate the lyophilization cycle
• Available lyophilizer size and commercial capacity
• Aseptic fill-finish capabilities (isolator or RABS)
• Regulatory inspection history (FDA, EMA, PMDA, etc.)
• Analytical and stability testing support
• Technology transfer and scale-up experience
• Potent compound or biologics handling, if applicable

If you're selecting a CDMO for a specific program, I can also recommend providers based on factors such as:

• Development stage (preclinical, Phase I–III, commercial)
• Product type (small molecule, peptide, protein, antibody, vaccine)
• Batch size
• Region (U.S., Europe, or Asia)
• Regulatory market (FDA, EMA, global)